Challenges with benchmarking of MDMA-assisted psychotherapy
- PMID: 34635857
- DOI: 10.1038/s41591-021-01525-0
Challenges with benchmarking of MDMA-assisted psychotherapy
Comment in
-
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.Nat Med. 2021 Oct;27(10):1691-1692. doi: 10.1038/s41591-021-01526-z. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635856 No abstract available.
Comment on
-
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. Nat Med. 2021. PMID: 33972795 Free PMC article. Clinical Trial.
References
-
- Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).
-
- American Psychological Association. Clinical practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults 1st edn (APA, 2017).
-
- National Institute for Health and Care Excellence. Post-traumatic Stress Disorder. NIC Guideline [NG116] (National Institute for Health and Care Excellence, 2018).
-
- Lee, D. J. et al. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta- analyses to determine first-line treatments. Depress. Anxiety 33, 792–806 (2016). - DOI
-
- Mavranezouli, I. et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol. Med. 50, 542–555 (2020). 130. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical